September 21, 2017

U.S. FDA Grants Orphan Drug Designation for ATB200/AT2221 for Pompe Disease

September 20, 2017

Amicus Therapeutics to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 19, 2017

U.S. FDA Grants Fast Track Designation for Amicus Therapeutics' Migalastat for Treatment of Fabry Disease